Pharmaceutical Preparations
Standard Industrial Classification: SIC 2834
Industry Insider Sentiment Analysis
The Pharmaceutical Preparations sector (SIC 2834) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-06 00:34 | 2026-05-04 | AXSM | Axsome Therapeutics, Inc. | Jacobson Mark L. | Officer | OPT+S | $227.95 | 4,750 | $1,082,771 | 0 |
| 2026-05-06 00:21 | 2026-05-01 | ARQT | Arcutis Biotherapeutics, Inc. | Welgus Howard G. | Director | SELL | $22.99 | 7,144 | $164,220 | 32,600 |
| 2026-05-05 23:53 | 2026-05-05 | NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Officer | SELL | $16.60 | 14,055 | $233,319 | 37,592 |
| 2026-05-05 23:47 | 2026-05-01 | TNGX | Tango Therapeutics, Inc. | Crystal Adam | Officer | OPT+S | $21.23 | 27,000 | $573,097 | 115,743 |
| 2026-05-05 21:53 | 2026-05-01 | CLNN | Clene Inc. | Ugwumba Chidozie | 10% owner | SELL | $6.74 | 78,679 | $530,438 | 198,890 |
| 2026-05-05 22:00 | 2026-05-04 | ACAD | ACADIA PHARMACEUTICALS INC | Schneyer Mark C. | Officer | OPT+S | $21.79 | 3,506 | $76,396 | 66,145 |
| 2026-05-05 22:00 | 2026-05-04 | ACAD | ACADIA PHARMACEUTICALS INC | Kihara James | Officer | OPT+S | $21.79 | 1,332 | $29,024 | 29,129 |
| 2026-05-05 21:11 | 2026-05-01 | VRTX | VERTEX PHARMACEUTICALS INC / MA | Liu Joy | Officer | SELL | $425.02 | 1,104 | $469,222 | 20,729 |
| 2026-05-05 20:30 | 2026-05-01 | CORT | CORCEPT THERAPEUTICS INC | BELANOFF JOSEPH K | Director, Officer | SELL | $50.10 | 40,000 | $2,003,860 | 2,878,326 |
| 2026-05-05 20:30 | 2026-05-01 | IONS | IONIS PHARMACEUTICALS INC | KLEIN JOSEPH III | Director | OPT+S | $73.51 | 10,111 | $743,238 | 11,014 |
| 2026-05-05 20:30 | 2026-05-04 | UTHR | UNITED THERAPEUTICS Corp | EDGEMOND JAMES | Officer | OPT+S | $576.93 | 10,000 | $5,769,338 | 18,876 |
| 2026-05-05 20:30 | 2026-05-01 | NUVL | Nuvalent, Inc. | Balcom Alexandra | Officer | OPT+S | $99.00 | 11,430 | $1,131,601 | 85,533 |
| 2026-05-05 20:31 | 2026-05-04 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $576.97 | 9,500 | $5,481,231 | 40,513 |
| 2026-05-05 20:18 | 2026-05-05 | CYTK | CYTOKINETICS INC | Lee Sung | Officer | SELL | $76.87 | 23,906 | $1,837,654 | 63,221 |
| 2026-05-05 20:18 | 2026-05-01 | STOK | Stoke Therapeutics, Inc. | Ticho Barry | Officer | SELL | $32.79 | 2,243 | $73,548 | 36,621 |
| 2026-05-05 19:51 | 2026-05-01 | PHVS | Pharvaris N.V. | Lu Peng | Officer | OPT+S | $30.17 | 14,166 | $427,418 | 66,083 |
| 2026-05-05 17:15 | 2026-05-04 | EWTX | Edgewise Therapeutics, Inc. | Donovan Joanne M. | Officer | OPT+S | $37.88 | 55,230 | $2,092,063 | 4,367 |
| 2026-05-04 20:22 | 2026-04-30 | BBIO | BridgeBio Pharma, Inc. | Apuli Maricel | Officer | SELL | $71.58 | 2,000 | $143,160 | 134,115 |
| 2026-05-05 00:42 | 2026-05-04 | ALKS | Alkermes plc. | Gaffin David Joseph | Officer | SELL | $33.20 | 2,034 | $67,529 | 231,558 |
| 2026-05-05 00:20 | 2026-05-01 | LGND | LIGAND PHARMACEUTICALS INC | Reardon Andrew | Officer | OPT+S | $231.31 | 5,000 | $1,156,556 | 41,382 |
| 2026-05-04 23:24 | 2026-05-04 | TRDA | Entrada Therapeutics, Inc. | Dowden Nathan J | Officer | OPT+S | $15.33 | 15,000 | $229,953 | 198,588 |
| 2026-05-04 23:25 | 2026-05-04 | TRDA | Entrada Therapeutics, Inc. | Sethuraman Natarajan | Officer | SELL | $15.39 | 25,907 | $398,810 | 216,317 |
| 2026-05-04 22:10 | 2026-05-04 | NRIX | Nurix Therapeutics, Inc. | Ring Christine | Officer | SELL | $16.96 | 8,148 | $138,210 | 18,305 |
| 2026-05-04 22:00 | 2026-04-30 | HOWL | Werewolf Therapeutics, Inc. | EVNIN LUKE | Director | SELL | $0.72 | 274,619 | $198,302 | 1,679,330 |
| 2026-05-04 22:02 | 2026-05-04 | SPTX | Seaport Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% owner | BUY | $18.00 | 1,100,000 | $19,800,000 | 6,294,951 |
| 2026-05-04 21:35 | 2026-05-01 | RARE | Ultragenyx Pharmaceutical Inc. | Horn Howard | Officer | SELL | $24.90 | 4,683 | $116,607 | 110,342 |
| 2026-05-04 21:28 | 2026-05-01 | EBS | Emergent BioSolutions Inc. | Zoon Kathryn C | Director | SELL | $8.40 | 17,202 | $144,454 | 79,941 |
| 2026-05-04 21:29 | 2026-04-30 | EBS | Emergent BioSolutions Inc. | Katkin Keith | Director | SELL | $8.28 | 15,481 | $128,183 | 96,294 |
| 2026-05-04 21:30 | 2026-05-01 | EBS | Emergent BioSolutions Inc. | DeGolyer Donald W | Director | SELL | $8.40 | 15,481 | $129,994 | 129,721 |
| 2026-05-04 21:30 | 2026-05-01 | EBS | Emergent BioSolutions Inc. | Dayal Sujata Tyagi | Director | SELL | $8.40 | 13,761 | $115,610 | 100,563 |
| 2026-05-04 20:54 | 2026-05-01 | UTHR | UNITED THERAPEUTICS Corp | ROTHBLATT MARTINE A | Director, Officer | OPT+S | $570.58 | 9,500 | $5,420,472 | 40,513 |
| 2026-05-04 20:27 | 2026-05-01 | TVTX | Travere Therapeutics, Inc. | Baynes Roy D. | Director | OPT+S | $44.22 | 9,750 | $431,145 | 37,500 |
| 2026-05-04 20:30 | 2026-05-01 | CAPR | CAPRICOR THERAPEUTICS, INC. | Bergmann Anthony | Officer | OPT+S | $31.70 | 25,000 | $792,540 | 8,223 |
| 2026-05-04 20:30 | 2026-05-01 | CAPR | CAPRICOR THERAPEUTICS, INC. | Krasney Karen | Officer | OPT+S | $31.70 | 25,000 | $792,548 | 30,547 |
| 2026-05-04 20:14 | 2026-05-01 | REGN | REGENERON PHARMACEUTICALS, INC. | RYAN ARTHUR F | Director | SELL | $705.24 | 100 | $70,524 | 17,503 |
| 2026-05-04 20:15 | 2026-05-01 | BLTE | BELITE BIO, INC | MATA NATHAN L. | Officer | SELL | $155.78 | 1,000 | $155,778 | 3,666 |
| 2026-05-04 20:00 | 2026-04-30 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Fox Christine | Officer | SELL | $35.31 | 21,258 | $750,620 | 63,647 |
| 2026-05-04 20:01 | 2026-05-01 | CYTK | CYTOKINETICS INC | Callos Andrew | Officer | OPT+S | $65.00 | 15,857 | $1,030,705 | 58,555 |
| 2026-05-04 20:02 | 2026-05-01 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sabag Mark | Officer | SELL | $34.99 | 144,180 | $5,045,118 | 80,760 |
| 2026-05-04 18:08 | 2026-05-01 | NTHI | NEONC TECHNOLOGIES HOLDINGS, INC. | Heshmatpour Amir F | Director, Officer, 10% owner | BUY | $4.16 | 10,000 | $41,592 | 3,072,000 |
| 2026-05-01 20:10 | 2026-04-29 | AIMD | Ainos, Inc. | chiang yao-chung | Director | BUY | $1.70 | 300 | $511 | 700 |
| 2026-05-02 01:34 | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Sloan Sheldon | Officer | OPT+S | $71.50 | 78,333 | $5,600,700 | 0 |
| 2026-05-02 01:35 | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Burrows Scott L | Officer | OPT+S | $71.37 | 12,500 | $892,125 | 97,994 |
| 2026-05-02 01:34 | 2026-05-01 | SYRE | Spyre Therapeutics, Inc. | Turtle Cameron | Director, Officer | SELL | $71.37 | 15,000 | $1,070,507 | 612,540 |
| 2026-05-02 01:05 | 2026-05-01 | ALKS | Alkermes plc. | Hopkinson Craig C. | Officer | OPT+S | $33.40 | 9,000 | $300,560 | 81,389 |
| 2026-05-01 23:30 | 2026-04-29 | PHVS | Pharvaris N.V. | Lesage Anne | Officer | OPT+S | $30.23 | 48,300 | $1,459,969 | 133,969 |
| 2026-05-01 23:32 | 2026-04-29 | PHVS | Pharvaris N.V. | Schikan Johannes Gerardus Christiaan Petrus | Director | SELL | $30.29 | 32,900 | $996,544 | 355,167 |
| 2026-05-01 23:09 | 2026-04-29 | PHVS | Pharvaris N.V. | Lu Peng | Officer | OPT+S | $30.21 | 18,733 | $565,858 | 66,083 |
| 2026-05-01 22:50 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | Carroll Jill | Director | BUY | $18.00 | 277,778 | $5,000,004 | 2,186,562 |
| 2026-05-01 22:46 | 2026-05-01 | AVLN | Avalyn Pharma Inc. | SR ONE CAPITAL MANAGEMENT, LLC | 10% owner | BUY | $18.00 | 555,555 | $9,999,990 | 1,122,087 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Pharmaceutical Preparations sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (2834) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Pharmaceutical Preparations
Every transaction in the Pharmaceutical Preparations industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.